Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript
Buy Rating Affirmed for MiMedx on Strong Performance and Favorable Market Outlook
Q1 2024 MiMedx Group Inc Earnings Call
MDXG: MACs Give Credit for Efficacy
MiMedx Group: Strong Financial Performance and Future Growth Potential Affirm Buy Rating
MiMedx Group: Strong Financial Performance and Future Growth Potential Affirm Buy Rating
MiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial ...
MiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial Performance and Strategic Market Moves
Q1 2024 MiMedx Group Inc Earnings Call Transcript
MIMEDX Announces First Quarter 2024 Operating and Financial Results
MIMEDX Announces First Quarter 2024 Operating and Financial Results
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
MDXG: Legal Avenues
MDXG: Legal Avenues
MiMedx Group (MDXG) Receives a Buy from Northland Securities
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
Investing in MiMedx Group (NASDAQ:MDXG) a year ago would have delivered you a 138% gain
Northland Securities Keeps Their Buy Rating on MiMedx Group (MDXG)
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.